Transactivation of platelet-derived growth factor receptor α by the GTPase-deficient activated mutant of Gα12

Molecular and Cellular Biology

Volumn 26, Issue 1, 2006, Pages 50-62

  Kumar, Rashmi N ^a   Ha, Ji Hee ^a   Radhakrishnan, Rangasudhagar ^a   Dhanasekaran, Danny N ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANOSINE TRIPHOSPHATASE; MUTANT PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSCRIPTION FACTOR FKHR; FORKHEAD TRANSCRIPTION FACTOR; FOXO3 PROTEIN, MOUSE; ONCOPROTEIN;

ANIMAL CELL; ARTICLE; ASTROCYTOMA; AUTOCRINE EFFECT; CARCINOGENESIS; CELL GROWTH; CELL STRAIN 3T3; CONTROLLED STUDY; DNA MICROARRAY; ENZYME DEFECT; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; CELL PROLIFERATION; CELL TRANSFORMATION; DOMINANT GENE; GENETICS; METABOLISM; MUTATION; TRANSACTIVATION;

ANIMALIA;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; FORKHEAD TRANSCRIPTION FACTORS; GENES, DOMINANT; GTP-BINDING PROTEIN ALPHA SUBUNITS, G12-G13; MICE; MUTATION; NIH 3T3 CELLS; ONCOGENE PROTEIN V-AKT; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RHO GTP-BINDING PROTEINS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC;

EID: 33645230802     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.26.1.50-62.2006     Document Type: Article

References (46)

1. Aragay, A. M., L. R. Collins, G. R. Post, A. J. Watson, J. R. Feramisco, J. H. Brown, and M. I. Simon. 1995. G12 requirement for thrombin-stimulated gene expression and DNA synthesis in 1321N1 astrocytoma cells. J. Biol. Chem. 270:20073-20077.
2. Baudhuin, L. M., Y. Jiang, A. Zaslawsky, I. Ishii, J. Chun, and Y. Xu. 2004. S1P3-mediated Akt activation and cross-talk with platelet-derived growth factor receptor (PDGFR). FASEB J. 18:341-343.
3. Benard, V., and G. M. Bokoch. 2002. Assay of Cdc42, Rac, and Rho GTPase activation by affinity methods. Methods Enzymol. 345:349-359.
4. Birkenkamp, K. U., and P. J. Coffer. 2003. Regulation of cell survival and proliferation by the FOXO (Forkhead box, class O) subfamily of Forkhead transcription factors. Biochem. Soc. Trans. 31:292-297.
5. 12 gene product. Mol. Cell. Biol. 2:762-768.
6. Chang, Y., B. Ceacareanu, M. Dixi, N. Sreejayan, and A. Hassid. 2002. Nitric oxide-induced motility in aortic smooth muscle cells. Role of protein tyrosine phosphatase SHP-2 and GTP-binding protein Rho. Circ. Res. 91:390-397.
7. Collins, L. R., W. A. Ricketts, J. M. Olefsky, and J. H. Brown. 1997. The G12 coupled thrombin receptor stimulates mitogenesis through the She SH2 domain. Oncogene 15:595-600.
8. Cox, A. D., and C. J. Der. 1994. Biological assays for cellular transformation. Methods Enzymol. 238:277-294.
9. Dai, C., J. C. Celestino, Y. Okada, D. N. Louis, G. N. Fuller, and E. C. Holland. 2001. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev. 15:1913-1925.
10. 12. Methods Enzymol. 344:298-309.
11. Dhanasekaran, N., and J. M. Dermott. 1996. Signaling by the G12 class of G proteins. Cell Signal. 8:235-245.
12. Ding, H., A. Nagy, D. H. Guttman, and A. Guha. 2000. A review of astrocytoma models. Neurosurg. Focus 8:1-8.
13. Fang, X., D. Gaudette, T. Furui, M. Mao, V. Estrella, A. Eder, T. Pustilnik, T. Sasagawa, R. Lapushin, S. Yu, R. B. Jaffe, J. R. Wiener, J. R. Erickson, and G. B. Mills. 2000. Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer. Ann. N. Y. Acad. Sci. 905:188-208.
14. 12 to the serum response element and to cellular transformation. Proc. Natl. Acad. Sci. USA 94:10098-10103.
15. 13-subunits of heterotrimeric G proteins: a novel family of oncogenes, p. 101-117. In S. Spiegel (ed.), G proteins, receptors, and diseases ed. Humana Press, Totowa, N.J.
16. Hanahan, D., and R. A. Weinberg. 2000. The hallmarks of cancer. Cell 100:57-70.
17. Heinrich, M. C., C. L. Corless, A. Duensing, L. McGreevey, C. J. Chen, N. Joseph, S. Singer, D. J. Griffith, A. Haley, A. Town, G. D. Demetri, C. D. Fletcher, and J. A. Fletcher. 2003. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 299:708-710.
18. Heldin, C. H., A. Ostman, and L. Ronnstrand. 1998. Signal transduction via platelet-derived growth factor receptors. Biochim. Biophys. Acta 1378:F79-F113.
19. Henriksen, R., K. Funa, E. Wilander, T. Backstrom, M. Ridderheim, and K. Oberg. 1993. Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms. Cancer Res. 53:4550-4554.
20. Herrlich, A., H. Daub, A. Knebel, P. Herrlich, A. Ullrich, G. Schultz, and T. Gudermann. 1998. Ligand-independent activation of platelet-derived growth factor receptor is a necessary intermediate in lysophosphatidic, acid-stimulated mitogenic activity in L cells. Proc. Natl. Acad. Sci. USA 95:8985-8990.
21. Hu, Y. L., C. Albanese, R. G. Pestell, and R. B. Jaffe. 2003. Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells. J. Natl. Cancer Inst. 95:733-740.
22. Ikuno, Y., and A. Kazlauskas. 2002. An in vivo gene therapy approach for experimental proliferative vitreoretinopathy using the truncated platelet-derived growth factor alpha receptor. Investig. Ophthalmol. Vis. Sci. 43:2406-2411.
23. Janssen, R. A., P. N. Kim, J. W. Mier, and D. K. Morrison. 2003. Overexpression of kinase suppressor of Ras upiegulates the high-molecular-weight tropomyosin isoforms in ras-transformed NIH 3T3 fibroblasts. Mol. Cell. Biol. 23:1786-1797.
24. Kawagishi, J., T. Kumabe, T. Yoshimoto, and T. Yamamoto. 1995. Structure, organization, and transcription units of the human alpha-platelet-derived growth factor receptor gene, PDGFRA. Genomics 30:224-232.
25. 12. Cell Biochem. Biophys. 41:63-73.
26. Lin, T., L. Zeng, Y. Liu, K. DeFea, M. A. Schwartz, S. Chien, and J. Y.-J. Shyly. 2003. Rho-ROCK-LIMK-Cofilin pathway regulates shear stress activation of sterol regulatory element binding proteins. Circ. Res. 92:1296-1304.
27. Lokker, N. A., C. M. Sullivan, S. J. Hollenbach, M. A. Israel, and N. A. Giese. 2002. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. Cancer Res. 62:3729-3735.
28. Martinez-Gac, L., M. Marques, Z. Garcia, M. R. Campanero, and A. C. Carrera. 2004. Control of cyclin G2 mRNA expression by forkhead transcription factors: novel mechanism for cell cycle control by phosphoinositide 3-kinase and forkhead. Mol. Cell. Biol. 24:2181-2189.
29. Martinez-Gac, L., B. Alvarez, Z. Garcia, M. Marques, M. Arrizabalaga, and A. C. Carrera. 2004. Phosphoinositide 3-kinase and forkhead, a switch for cell division. Biochem. Soc. Trans. 32:360-361.
30. Matei, D., D. D. Chang, and M. H. Jeng. 2004. Imatinib mesylate (Gleevec) inhibits ovarian cancer cell growth through a mechanism dependent on platelet-derived growth factor receptor alpha and Akt inactivation. Clin. Cancer Res. 10:681-690.
31. 13 with the cytoplasmic domain of cadherin provides a mechanism for β-catenin release. Proc. Natl. Acad. Sci. USA 98:519-524.
32. Mondorf, U. F., H. Geiger, M. Herrero, S. Zeuzem, and A. Piiper. 2000. Involvement of the platelet-derived growth factor receptor in angiotensin II-induced activation of extracellular regulated kinases 1 and 2 in human mesangial cells. FEBS Lett. 472:129-132.
33. Nebigil, C. G., J. M. Launay, P. Hickel, C. Tournois, and L. Maroteaux. 2000. 5-hydroxytryptamine 2B receptor regulates cell-cycle progression: cross-talk with tyrosine kinase pathways. Proc. Natl. Acad. Sci. USA 97:2591-2596.
34. Pleiman, C. M., M. R. Clark, L. K. Gauen, S. Winitz, K. M. Coggeshall, G. L. Johnson, A. S. Shaw, and J. C. Cambier. 1993. Mapping of sites on the Src family protein tyrosine kinases p55blk, p59fyn, and p56lyn, which interact with the effector molecules phospholipase C-gamma 2, microtubule-associated protein kinase, GTPase-activating protein, and phosphatidylinositol 3-kinase. Mol. Cell. Biol. 13:5877-5887.
35. Radhika, V., and N. Ohanasekaran. 2001. Transforming G proteins. Oncogene 20:1607-1614.
36. 13 stimulates cell migration through cortactin-interacting protein Hax-1. J. Biol. Chem. 279:49406-49413.
37. 12. Oncogene 24:4597-4603.
38. Ren, X. D., and M. A. Schwartz. 2000. Determination of GTP loading on Rho. Methods Enzymol. 325:264-272.
39. Saito, Y., and B. C. Berk. 2001. Transactivation: a novel signaling pathway from angiotensin II to tyrosine kinase receptors. J. Mol. Cell. Cardiol. 33:3-7.
40. Seasholtz, T. M., J. Radeff-Huang, S. A. Sagi, R. Matteo, J. M. Weema, A. S. Cohen, J. R. Feramisco, and J. H. Brown. 2004. Rho-mediated cytoskeletal rearrangement in response to LPA is functionally antagonized by Rac1 and PIP2. J. Neurochem. 91:501-502.
41. Tang, P., P. A. Steck, and W. K. Yung. 1997. The autocrine loop of TGF-α/EGFR and brain tumors. J. Neurooncol. 35:303-314.
42. Uren, A, M. S. Merchant, C. J. Sun, M. I. Vitolo, Y. Sun, M. Tsokoa, P. B. Illlei, M. Ladanyi, A. Passaniti, C. Mackall, and J. A. Toretsky. 2003. Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells. Oncogene 22:2334-2342.
43. 13 induces Egr-1, c-fos, and transformation in NIH 3T3 cells. Oncogene 9:2425-2429.
44. 13. J. Biol. Chem. 270:18655-18659.
45. Xie, J., M. Aszterbaum, X. Zhang, J. M. Bonifas, C. Zachary, E. Epstein, and F. McCormick. 2001. A role of PDGFRα in basal cell carcinoma proliferation. Proc. Natl. Acad. Sci. USA 98:9255-9259.
46. Yokote, K., B. Margolis, C. H. Heldin, and L. Claesson-Welsh. 1996. Grb7 is a downstream signaling component of platelet-derived growth factor α- and β-receptors. J. Biol. Chem. 271:30942-30949.